Reported valuation; nothing comparable since.
- ·7 fund marks: filer, period, implied $/share
Membership and data by Private Market View
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Avalyn Pharma funding history
No funding rounds for Avalyn Pharma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Avalyn Pharma valuation
Avalyn Pharma is valued at approximately $155 million as of Oct 2026. The figure is set by institutional fund marks.
Recent activity
In the last 90 days, Avalyn Pharma's record added 6 institutional fund marks (latest period Jul 2026).
Institutional holders and vehicles
3 SEC-registered funds reported 7 fair-value marks on Avalyn Pharma between May 2026 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
How Avalyn Pharma's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Avalyn Pharma, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by institutional fund marks. Question about this number? Full methodology →
Frequently asked about Avalyn Pharma
- What is Avalyn Pharma worth?
- Avalyn Pharma is valued at $155.0M as of Oct 2026. Reported valuation; nothing comparable since.
- How much has Avalyn Pharma raised?
- Avalyn Pharma has raised $386.7M in total funding across its recorded rounds.